INVIVO THERAPEUTICS HOLDINGS CORP.·4

Nov 21, 5:05 PM ET

CHRISTOPHER RICHARD 4

4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Nov 21, 2022

Insider Transaction Report

Form 4
Period: 2022-11-17
CHRISTOPHER RICHARD
CFO and Treasurer
Transactions
  • Award

    Stock Option (right to buy)

    2022-11-17+20,80020,800 total
    Exercise: $2.50Exp: 2032-11-16Common Stock (20,800 underlying)
Footnotes (1)
  • [F1]The option was granted on November 17, 2022. The shares underlying the option vest over two years, with 50% of the shares vesting on November 17, 2023 and the remaining shares vesting on November 17, 2024.

Documents

1 file
  • 4
    tm2231056-8_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT